Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …

Introduction: Recently, the evidence on efficacy and safety of prophylactic HPV vaccines
derived from randomized trials was published in the Cochrane database of Systematic …

Background The knowledge that persistent human papillomavirus (HPV) infection is the
main cause of cervical cancer has resulted in the development of prophylactic vaccines to …

Abstract Established Human Papillomavirus (HPV) types, up to HPV202, belong to 49
species in five genera. International standardization in classification and quality standards …

Human papillomavirus (HPV) causes virtually all cervical cancers and many cancers at other
anatomical sites in both men and women. However, only 12 of 448 known HPV types are …

Abstract In 2012, the International Agency for Research on Cancer concluded that there was
consistent and sufficient epidemiological, experimental and mechanistic evidence of …

Background Testing for high-risk HPV is more effective in primary cervical cancer screening
than the cytological examination of a Pap smear. Separate genotyping may be useful for …

Glycosaminoglycans (GAGs) are complex carbohydrates that are ubiquitously present on
the cell surface and in the extracellular matrix. Interactions between GAGs and pathogens …

Although the role of oncogenic human Alpha‐papillomaviruses (HPVs) in the development
of mucosal carcinomas at different body sites (eg cervix, anus, oropharynx) is fully …

Cervical cancer (CC) continues to be a major public health problem in Mexico, ranking
second among cancers in women. A persistent infection with human papillomaviruses (HPV) …